These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20368235)

  • 41. Cardiovascular clinical trials in patients with diabetes mellitus: lessons from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study.
    Solomon SD
    Circulation; 2010 Jun; 121(22):2453-5. PubMed ID: 20530024
    [No Abstract]   [Full Text] [Related]  

  • 42. Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial.
    Damluji AA; Cohen ER; Moscucci M; Myerburg RJ; Cohen MG; Brooks MM; Rich MW; Forman DE
    Int J Cardiol; 2017 Aug; 241():35-40. PubMed ID: 28314486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease.
    Pallisgaard JL; Brooks MM; Chaitman BR; Boothroyd DB; Perez M; Hlatky MA;
    Am J Med; 2018 Jul; 131(7):805-812. PubMed ID: 29581079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.
    Dagenais GR; Lu J; Faxon DP; Bogaty P; Adler D; Fuentes F; Escobedo J; Krishnaswami A; Slater J; Frye RL;
    J Am Coll Cardiol; 2013 Feb; 61(7):702-11. PubMed ID: 23410541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database.
    McGuire DK; Anstrom KJ; Peterson ED
    Circulation; 2003 Apr; 107(14):1864-70. PubMed ID: 12668513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronary artery bypass grafting (CABG): reassessing efficacy, safety, and cost.
    Cundiff DK
    MedGenMed; 2002 Jun; 4(2):7. PubMed ID: 12145567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of type 2 diabetes: New clinical studies and effects of GLP-1 on macrovascular complications.
    Lesven S; Gautier JF; Maréchaud R
    Ann Endocrinol (Paris); 2010 Dec; 71(6):505-10. PubMed ID: 21030006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D Clinical Trial).
    Krishnaswami A; Hardison R; Nesto RW; Sobel B;
    Am J Cardiol; 2012 Jan; 109(1):36-41. PubMed ID: 21958742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial.
    Vaccaro O; Masulli M; Bonora E; Del Prato S; Giorda CB; Maggioni AP; Mocarelli P; Nicolucci A; Rivellese AA; Squatrito S; Riccardi G;
    Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):997-1006. PubMed ID: 23063367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM; Boden WE; Frye RL
    Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factor control for coronary artery disease secondary prevention in large randomized trials.
    Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V
    J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.
    Althouse AD; Abbott JD; Forker AD; Bertolet M; Barinas-Mitchell E; Thurston RC; Mulukutla S; Aboyans V; Brooks MM;
    Diabetes Care; 2014; 37(5):1346-52. PubMed ID: 24595631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Althouse AD; Abbott JD; Sutton-Tyrrell K; Forker AD; Lombardero MS; Buitrón LV; Pena-Sing I; Tardif JC; Brooks MM;
    Diabetes Care; 2013 Oct; 36(10):3269-75. PubMed ID: 23735723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Has anything changed in multivessel coronary artery revascularization in diabetes since BARI?
    Kapur A; Bartolini D; Beatt KJ
    Ital Heart J; 2004 May; 5(5):358-63. PubMed ID: 15185899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease.
    Tsujimoto T; Kajio H
    Int J Cardiol; 2019 May; 282():1-6. PubMed ID: 30772014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus.
    Galligan A; Greenaway TM
    Intern Med J; 2016 May; 46(5):540-9. PubMed ID: 27170238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis.
    Ismail-Beigi F; Lombardero MS; Escobedo J; Genuth S; Green J; Massaro E; Mooradian AD; Ovalle F; Whitehouse F; Zonszein J;
    J Diabetes Complications; 2014; 28(1):101-9. PubMed ID: 23478173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.